0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV--PremiumOct 18, 2024Expiry Date2.50Intrinsic Value100Multiplier16DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Better Therapeutics Stock Discussion
4 MINUTES AGO, 8:55 AM EDT
VIA BUSINESSWIRESHARE
• Better Therapeutics assets include the first FDA-authorized prescription digital therapeutic for type 2 diabetes, AspyreRx, as well as development candidates BT-002, BT-003 and BT-004 for hypertension, hyperlipidemia, and MASH.
• Initial efforts will focus on further develo...
No comment yet